If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksICP.L Share News (ICP)

  • There is currently no data for ICP

Monday broker round-up

Mon, 19th Nov 2018 12:13
(Sharecast News) - Sainsbury: Berenberg reiterates buy with a target price of 369p.Prudential: Deutsche Bank reiterates buy with a target price of 2,100p.S&U: Shore Capital Markets reiterates hold with a target price of 2,475p.CYBG: Shore Capital Markets reiterates hold.Intermediate Capital Group: Shore Capital Markets reiterates hold.Diploma: RBC Capital Markets reiterates sector perform with a target price of 1,280p.AstraZeneca: Barclays reiterates overweight with a target price of 6,800p.Cobham: Barclays reiterates equal weight with a target price of 110p.Premier Oil: Barclays reiterates overweight with a target price of 130p.Greencore: Peel Hunt reiterates hold with a target price of 170p.Genus: Peel Hunt reiterates hold with a target price of 2,600p.Mitie: Liberum reiterates buy with a target price of 210p.BBA Aviation: JP Morgan reiterates overweight with a target price of 354p.Royal Mail: JP Morgan reiterates neutral with a target price of 285p.Intermediate Capital Group: JP Morgan reiterates overweight with a target price of 1,450p.888 Holdings: Canaccord reiterates buy with a target price of 300p.GVC Holdings: Canaccord reiterates buy with a target price of 1,200p.GoCompare: Berenberg reiterates buy with a target price of 150p.

Related News

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears
2 hours ago

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears

(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike...

Hutchmed drug approved in China for advanced gastric cancer
5 hours ago

Hutchmed drug approved in China for advanced gastric cancer

(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer wi...

AstraZeneca signs CSPC China deal for experimental kidney disease drugs
8 hours ago

AstraZeneca signs CSPC China deal for experimental kidney disease drugs

July 2 (Reuters) - AstraZeneca ​has entered into a deal worth up to $1.77 billion ​with ‌CSPC Pharmaceutical Group to discover and develop experimenta...

ICP.L News

LONDON BROKER RATINGS: JPMorgan raises M&S; HSBC likes Kingfisher
11 Apr 2024

LONDON BROKER RATINGS: JPMorgan raises M&S; HSBC likes Kingfisher

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Marston's Chair William Rucker to leave to take chair of British Land
11 Mar 2024

Marston's Chair William Rucker to leave to take chair of British Land

(Alliance News) - British Land Co PLC on Monday said it appointed Marston's PLC Chair William Rucker as chair designate, with Rucker leaving the Marst...

LONDON BROKER RATINGS: Morgan Stanley ups Rightmove; Deutsche cuts IHG
26 Jan 2024

LONDON BROKER RATINGS: Morgan Stanley ups Rightmove; Deutsche cuts IHG

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

London close: Stocks turn green after US GDP release
25 Jan 2024

London close: Stocks turn green after US GDP release

(Sharecast News) - Stocks in London had turned higher by the close on Thursday, as investors digested a better-than-expected GDP reading out of the Un...

Intermediate Capital hails balance sheet as assets under management up
25 Jan 2024

Intermediate Capital hails balance sheet as assets under management up

(Alliance News) - Intermediate Capital Group PLC on Thursday reported a rise in assets under management, as it noted sound capitalisation and a "valua...

Intermediate Capital hits fundraising target early as AUM grows in Q3
25 Jan 2024

Intermediate Capital hits fundraising target early as AUM grows in Q3

(Sharecast News) - The share price of Intermediate Capital Group jumped on Thursday after the private equity investment firm reported a solid increase...

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group
10 Jan 2024

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: